Clinical studiesThe impact of treatment with omeprazole on the effectiveness of clopidogrel drug therapy during the first year after successful coronary stentingLes effets du traitement à l’oméprazole sur l’efficacité d’une pharmacothérapie au clopidogrel pendant la première année suivant l’installation réussie d’une endoprothèse coronaire
References (19)
- et al.
Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: The role of dual drug resistance
J Am Coll Cardiol
(2006) - et al.
Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: The randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study
J Am Coll Cardiol
(2008) - et al.
The impact of oral antiplatelet responsiveness on the long-term prognosis after coronary stenting
Am Heart J
(2007) - et al.
Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects
Blood
(2006) - et al.
TIMI 22 Investigators. High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients – a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis
Am Heart J
(2008) - et al.
CHARISMA Investigators. Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial
J Am Coll Cardiol
(2007) - et al.
The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes
Eur Heart J
(2007) - et al.
Evaluation of proton pump inhibitor use in patients with acute coronary syndromes based on risk factors for gastrointestinal bleed
Crit Pathw Cardiol
(2007) - et al.
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
Circulation
(2008)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2010 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.